GUIDELINES FOR THE TRANSFUSION OF PLATELETS

Abstract Recommendations aiming at standardising and rationalising clinical indications for the transfusion of platelets in Belgium were drawn up by a working group of the Superior Health Council. To this end the Superior Health Council organised an expert meeting devoted to “Guidelines for the transfusion of platelets” in collaboration with the Belgian Hematological Society. The experts discussed the indications for platelet transfusions, the ideal platelet concentrate and the optimal platelet transfusion therapy. The recommendations prepared by the experts were validated by the working group with the purpose of harmonising platelet transfusion in Belgian hospitals.

[1]  M. Toungouz,et al.  GUIDELINES FOR THE TRANSFUSION OF PLATELETS , 2007, Acta clinica Belgica.

[2]  Indira Hewlett,et al.  Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology: update to 2003 , 2005 .

[3]  Paul J. Harrison,et al.  Accuracy of platelet counting haematology analysers in severe thrombocytopenia and potential impact on platelet transfusion , 2005, British journal of haematology.

[4]  B. Giraudeau,et al.  The efficiency of transfusing high doses of platelets in hematologic patients with thrombocytopenia: results of a prospective, randomized, open, blinded end point (PROBE) study. , 2005, Blood.

[5]  I. Tannock,et al.  Low‐dose prophylactic platelet transfusions in recipients of an autologous peripheral blood progenitor cell transplant and patients with acute leukemia: a randomized controlled trial with a sequential Bayesian design , 2004, Transfusion.

[6]  P. Rebulla,et al.  Prophylactic platelet transfusion for haemorrhage after chemotherapy and stem cell transplantation. , 2004, The Cochrane database of systematic reviews.

[7]  N. Blumberg,et al.  Optimizing platelet transfusion therapy. , 2004, Blood reviews.

[8]  S. Slichter.  Platelet transfusion: future directions , 2004, Vox sanguinis.

[9]  S. Slichter.  Relationship between platelet count and bleeding risk in thrombocytopenic patients. , 2004, Transfusion medicine reviews.

[10]  L. Williamson.  ES04.03 
Correcting haemostasis , 2004 .

[11]  C. Prowse,et al.  Evaluation of stored platelets , 2004, Vox sanguinis.

[12]  C. Rodeck,et al.  Transfusion guidelines for neonates and older children , 2004, British journal of haematology.

[13]  G. Avvisati,et al.  Thrombocytopenia and hemorrhagic risk in cancer patients. , 2003, Critical reviews in oncology/hematology.

[14]  Guidelines for the use of platelet transfusions , 2003, British journal of haematology.

[15]  H. Gulliksson,et al.  In vivo and in vitro comparison of platelets stored in either synthetic media or plasma , 2003, Vox sanguinis.

[16]  K. Ahrar,et al.  Transjugular liver biopsy in patients with hematologic malignancy and severe thrombocytopenia. , 2003, Journal of vascular and interventional radiology : JVIR.

[17]  B. Pollock,et al.  A prospective randomized trial of prophylactic platelet transfusion and bleeding incidence in hematopoietic stem cell transplant recipients: 10,000/L versus 20,000/microL trigger. , 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[18]  J. AuBuchon,et al.  Seven‐day storage of single‐donor platelets: recovery and survival in an autologous transfusion study , 2002, Transfusion.

[19]  G. Ehninger,et al.  New strategies for prophylactic platelet transfusion in patients with hematologic diseases. , 2001, The oncologist.

[20]  S. Dzik.  Safety of lumbar puncture for children with acute lymphoblastic leukemia and thrombocytopenia , 2001 .

[21]  A. Brand.  Alloimmune platelet refractoriness:incidence declines, unsolved problems persist , 2001, Transfusion.

[22]  J M Rainey,et al.  Platelet transfusion for patients with cancer: clinical practice guidelines of the American Society of Clinical Oncology. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  M. Bins,et al.  Reactions and platelet increments after transfusion of platelet concentrates in plasma or an additive solution: a prospective, randomized study , 2000, Transfusion.

[24]  H. Reesink,et al.  Preparation of Leukodepleted Platelet Concentrates from Pooled Buffy Coats: Prestorage Filtration with Autostop™BC , 1999, Vox Sanguinis.

[25]  M. Sagmeister,et al.  A restrictive platelet transfusion policy allowing long-term support of outpatients with severe aplastic anemia. , 1999, Blood.

[26]  Kaaron Benson,et al.  Guide to the Preparation, Use and Quality Assurance of Blood Components , 1999 .

[27]  V. Novotny.  Prevention and Management of Platelet Transfusion Refractoriness , 1999, Vox Sanguinis.

[28]  Napier.  Guide to the Preparation, Use and Quality Assurance of Blood Components. , 1998 .

[29]  S. Holme.  Storage and Quality Assessment of Platelets , 1998, Vox sanguinis.

[30]  S. Murphy,et al.  A multi‐laboratory evaluation of in vitro platelet assays: the tests for extent of shape change and response to hypotonic shock. Biomedical Excellence for Safer Transfusion Working Party of the International Society of Blood Transfusion , 1998, Transfusion.

[31]  T. Barbui,et al.  The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto. , 1997, The New England journal of medicine.

[32]  A. Leavitt,et al.  Crossmatch‐compatible platelets improve corrected count increments in patients who are refractory to randomly selected platelets , 1997, Transfusion.

[33]  R. Strauss,et al.  Randomized study of prophylactic platelet transfusion threshold during induction therapy for adult acute leukemia: 10,000/microL versus 20,000/microL. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  H. Greinix,et al.  Specificities of anti‐platelet antibodies in multitransfused patients with haemato‐oncological disorders , 1996, British journal of haematology.

[35]  T. Deloughery,et al.  Invasive line placement in critically ill patients: do hemostatic defects matter? , 1996, Transfusion.

[36]  H. Northoff,et al.  Frequency and specificity of platelet‐specific alloantibodies in HLA‐immunized haematologic–oncologic patients , 1996, Transfusion medicine.

[37]  F. Claas,et al.  Occurrence of Allogeneic HLA and Non-HLA Antibodies After Transfusion of Prestorage Filtered Platelets and Red Blood Cells: A Prospective Study , 1995 .

[38]  F. Claas,et al.  Leukocyte depletion of random single-donor platelet transfusions does not prevent secondary human leukocyte antigen-alloimmunization and refractoriness: a randomized prospective study. , 1995, Blood.

[39]  E. Elonen,et al.  Adverse Reactions to Platelet Transfusions Are Reduced by Use of Platelet Concentrates Derived from Buffy Coat , 1994, Vox sanguinis.

[40]  L. Williamson,et al.  Bedside filtration of blood products in the prevention of HLA alloimmunization--a prospective randomized study. Alloimmunisation Study Group , 1994 .

[41]  E. Dupont,et al.  The SANGUIS Study in Belgium: an overview of methods and results. Safe and good use of blood in surgery. , 1994, Acta chirurgica Belgica.

[42]  J. Rowe,et al.  Selection of platelets for refractory patients by HLA matching and prospective crossmatching , 1992, Transfusion.

[43]  M. Hart,et al.  Central venous catheterization in patients with coagulopathy. , 1992, Archives of surgery.

[44]  J. Fehr,et al.  Safety of stringent prophylactic platelet transfusion policy for patients with acute leukaemia , 1991, The Lancet.

[45]  P. Toy,et al.  Lack of increased bleeding after liver biopsy in patients with mild hemostatic abnormalities. , 1990, American journal of clinical pathology.

[46]  J. Hutton,et al.  Transfusion of ABO‐mismatched platelets leads to early platelet refractoriness , 1990, British journal of haematology.

[47]  C. Schiffer,et al.  ABO compatibility can influence the results of platelet transfusion , 1989, Transfusion.

[48]  N. Hamajima,et al.  A notable change in mortality of aplastic anemia observed during the 1970s in Japan. , 1988, Blood.

[49]  Edward J. Lee,et al.  The value of 10‐minute posttransfusion platelet counts , 1988, Transfusion.

[50]  F. Claas,et al.  ABH antibodies causing platelet transfusion refractoriness , 1986, Transfusion.

[51]  L. Reich,et al.  Hemolysis following platelet transfusions from ABO‐incompatible donors , 1985, Transfusion.

[52]  T. Simon,et al.  Concentration of platelet units into small volumes , 1984, Transfusion.

[53]  S. Litwin,et al.  Indications for platelet transfusion in children with acute leukemia , 1982, American journal of hematology.

[54]  Harker La,et al.  Thrombocytopenia: mechanisms and management of defects in platelet production. , 1978, Clinics in haematology.

[55]  E. Beutler,et al.  PLATELET PROPHYLAXIS IN ACUTE NON-LYMPHOBLASTIC LEUKÆMIA , 1978, The Lancet.

[56]  J. Holland,et al.  The Prophylactic Treatment of Thrombocytopenic Leukemic Patients with Platelets: a Double Blind Study , 1974, Transfusion.

[57]  J. Posner,et al.  Spinal Subdural Hematomas Complicating Lumbar Puncture: Occurrence in Thrombocytopenic Patients , 1974 .

[58]  N. Jaffe,et al.  Prophylactic Platelet Transfusions in Children with Acute Leukemia: A Dose Response Study , 1973, Transfusion.

[59]  T. Han,et al.  Effect of platelet transfusion on hemorrhage in patients with acute leukemia: An autopsy study , 1966, Cancer.

[60]  N. Mantel,et al.  The quantitative relation between platelet count and hemorrhage in patients with acute leukemia. , 1962, The New England journal of medicine.

[61]  H..  Effect of Anticoagulant and ABO Incompatibility on Recovery of Transfused Human Platelets , 2005 .

[62]  L. Williamson.  Correcting haemostasis. , 2004, Vox sanguinis.

[63]  J. George.  Idiopathic thrombocytopenic purpura in adults: current issues for pathogenesis, diagnosis and management. , 2004, The hematology journal : the official journal of the European Haematology Association.

[64]  Jay S Epstein,et al.  Bacterial contamination of blood components: risks, strategies, and regulation: joint ASH and AABB educational session in transfusion medicine. , 2003, Hematology. American Society of Hematology. Education Program.

[65]  Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions. , 1997, The New England journal of medicine.

[66]  F. Claas,et al.  Occurrence of allogeneic HLA and non-HLA antibodies after transfusion of prestorage filtered platelets and red blood cells: a prospective study. , 1995, Blood.

[67]  L. Williamson,et al.  Bedside filtration of blood products in the prevention of HLA alloimmunization--a prospective randomized study. Alloimmunisation Study Group. , 1994, Blood.

[68]  J. Akkerman,et al.  Use of leukocyte-depleted platelet concentrates for the prevention of refractoriness and primary HLA alloimmunization: a prospective, randomized trial. , 1991, Blood.

[69]  L. Harker,et al.  Thrombocytopenia: mechanisms and management of defects in platelet production. , 1978, Clinics in haematology.

[70]  Standards for blood banks and transfusion services. , 1977, QRB. Quality review bulletin.

[71]  J. Posner,et al.  Spinal subdural hematomas complicating lumbar puncture. , 1974, Archives of neurology.